JZJulián Cuartas Zapata

Julián Cuartas Zapata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julián Cuartas Zapata has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute cerebral venous thrombosis in the setting of spontaneous intracranial hypotension during the postpartum period: A case report

    by Esteban Agudelo Quintero, Julián Cuartas Zapata, David Ríos Patiño, Adolfo León Vélez Aguirre

    Introduction: Cerebral venous thrombosis (CVT) is a rare, life-threatening complication of spontaneous intracranial hypotension (SIH). According to the Monro-Kellie doctrine, CSF depletion triggers compensatory venous dilatation and stasis, which, in prothrombotic states, facilitates thrombus formation. This report describes CVT secondary to SIH during the postpartum period. Case presentation: A 31-year-old postpartum woman presented with an orthostatic headache, neck pain, and photophobia. Brain MRI demonstrated pachymeningeal enhancement and cerebellar tonsillar descent, while MRV confirmed extensive CVT. Spinal imaging identified a CSF leak at C7–C8. The patient received systemic anticoagulation without an epidural blood patch, achieving complete clinical recovery and radiological recanalization at six months. Discussion: The synergy between mechanical venous distension from SIH and postpartum hypercoagulability precipitates CVT. This association is often underdiagnosed because the acute symptoms of venous thrombosis can mask the underlying intracranial hypotension. Conclusions: Maintaining a high index of suspicion for CVT in patients with SIH—especially when headache semiology changes—is crucial. Early recognition allows for integrated management and prevents permanent neurological deficits.

  • Open Access

    Gepants: Key Features of A Potent Therapeutic Option and Considerations in The Latin American Context

    by David Ríos Patiño, Julián Cuartas Zapata, Adolfo León Vélez Aguirre

    Migraine is a complex condition when considered from the perspective of its pathophysiology. Moreover, it is highly prevalent and of priority interest in public health. Gepants are a highly-effective and specific therapeutic option, although their recent arrival in Latin America raises particular questions and expectations. A narrative review of the four medications available outside Latin America at this time is provided and the main considerations that should be borne in mind before and during their adoption are presented. Appropriate patient selection and marketing cost will be key determinants for their consolidation as an alternative to traditional medications used in migraine.